Antibiotic Dosing in Pediatric Intensive Care
Launched by UNIVERSITY HOSPITAL, GHENT · May 26, 2015
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different antibiotics work in critically ill children, including neonates, infants, and older kids. Specifically, the researchers want to understand how well the body absorbs and processes antibiotics like piperacillin-tazobactam, amoxicillin-clavulanate, vancomycin, and others when given to patients in the pediatric intensive care unit (PICU). The goal is to improve treatment by finding the best dosing for these medications in young patients who are very sick.
To participate in this study, children aged between 1 month and 15 years who are being treated with these antibiotics in the PICU may be eligible. They should have a way for doctors to take blood samples, like an intravenous line, and must not have certain allergies or medical conditions that could complicate the study. Participants can expect to have some blood tests done to help researchers learn how the antibiotics are working in their bodies. This research is important because better understanding antibiotic dosing can lead to more effective treatments for critically ill children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients admitted to the pediatric intensive care unit
- • patient age/weight : 1,8 kg-15 years
- • patient receiving antibiotic treatment (piperacillin-tazobactam, amoxicillin-clavulanate, vancomycin, teicoplanin, meropenem, ciprofloxacin, amikacin) via intermittent infusion regimen or continuous infusion according to institutional treatment guidelines
- • intra-arterial or intravenous access other than the drug infusion line available for blood sampling (arterial line is preferred)
- Exclusion Criteria:
- • no catheter in place for blood sampling
- • absence of parental/patient consent
- • known hypersensitivity to beta-lactam antibiotics, glycopeptides, fluoroquinolones, aminoglycosides
- • extracorporeal circuit (haemodialysis, ECMO, peritoneal dialysis )
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, , Belgium
Patients applied
Trial Officials
Pieter De Cock
Principal Investigator
University Hospital, Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials